Cargando…
Application of Radiosensitizers in Cancer Radiotherapy
Radiotherapy (RT) is a cancer treatment that uses high doses of radiation to kill cancer cells and shrink tumors. Although great success has been achieved on radiotherapy, there is still an intractable challenge to enhance radiation damage to tumor tissue and reduce side effects to healthy tissue. R...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886779/ https://www.ncbi.nlm.nih.gov/pubmed/33603370 http://dx.doi.org/10.2147/IJN.S290438 |
_version_ | 1783651869340467200 |
---|---|
author | Gong, Liuyun Zhang, Yujie Liu, Chengcheng Zhang, Mingzhen Han, Suxia |
author_facet | Gong, Liuyun Zhang, Yujie Liu, Chengcheng Zhang, Mingzhen Han, Suxia |
author_sort | Gong, Liuyun |
collection | PubMed |
description | Radiotherapy (RT) is a cancer treatment that uses high doses of radiation to kill cancer cells and shrink tumors. Although great success has been achieved on radiotherapy, there is still an intractable challenge to enhance radiation damage to tumor tissue and reduce side effects to healthy tissue. Radiosensitizers are chemicals or pharmaceutical agents that can enhance the killing effect on tumor cells by accelerating DNA damage and producing free radicals indirectly. In most cases, radiosensitizers have less effect on normal tissues. In recent years, several strategies have been exploited to develop radiosensitizers that are highly effective and have low toxicity. In this review, we first summarized the applications of radiosensitizers including small molecules, macromolecules, and nanomaterials, especially those that have been used in clinical trials. Second, the development states of radiosensitizers and the possible mechanisms to improve radiosensitizers sensibility are reviewed. Third, the challenges and prospects for clinical translation of radiosensitizers in oncotherapy are presented. |
format | Online Article Text |
id | pubmed-7886779 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-78867792021-02-17 Application of Radiosensitizers in Cancer Radiotherapy Gong, Liuyun Zhang, Yujie Liu, Chengcheng Zhang, Mingzhen Han, Suxia Int J Nanomedicine Review Radiotherapy (RT) is a cancer treatment that uses high doses of radiation to kill cancer cells and shrink tumors. Although great success has been achieved on radiotherapy, there is still an intractable challenge to enhance radiation damage to tumor tissue and reduce side effects to healthy tissue. Radiosensitizers are chemicals or pharmaceutical agents that can enhance the killing effect on tumor cells by accelerating DNA damage and producing free radicals indirectly. In most cases, radiosensitizers have less effect on normal tissues. In recent years, several strategies have been exploited to develop radiosensitizers that are highly effective and have low toxicity. In this review, we first summarized the applications of radiosensitizers including small molecules, macromolecules, and nanomaterials, especially those that have been used in clinical trials. Second, the development states of radiosensitizers and the possible mechanisms to improve radiosensitizers sensibility are reviewed. Third, the challenges and prospects for clinical translation of radiosensitizers in oncotherapy are presented. Dove 2021-02-12 /pmc/articles/PMC7886779/ /pubmed/33603370 http://dx.doi.org/10.2147/IJN.S290438 Text en © 2021 Gong et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Gong, Liuyun Zhang, Yujie Liu, Chengcheng Zhang, Mingzhen Han, Suxia Application of Radiosensitizers in Cancer Radiotherapy |
title | Application of Radiosensitizers in Cancer Radiotherapy |
title_full | Application of Radiosensitizers in Cancer Radiotherapy |
title_fullStr | Application of Radiosensitizers in Cancer Radiotherapy |
title_full_unstemmed | Application of Radiosensitizers in Cancer Radiotherapy |
title_short | Application of Radiosensitizers in Cancer Radiotherapy |
title_sort | application of radiosensitizers in cancer radiotherapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886779/ https://www.ncbi.nlm.nih.gov/pubmed/33603370 http://dx.doi.org/10.2147/IJN.S290438 |
work_keys_str_mv | AT gongliuyun applicationofradiosensitizersincancerradiotherapy AT zhangyujie applicationofradiosensitizersincancerradiotherapy AT liuchengcheng applicationofradiosensitizersincancerradiotherapy AT zhangmingzhen applicationofradiosensitizersincancerradiotherapy AT hansuxia applicationofradiosensitizersincancerradiotherapy |